The plant will mainly cater to the more regulated international markets such as the US, Brazil and Germany
Torrent Pharma has commenced commercial operations at its new plant in Dahej. This is the company’s fifth formulation plant and the second API plant. The facility is being set up in two phases. The total investment made in the first phase of the plant is over Rs 650 crores.
The new plant, situated in Dahej SEZ is spread across 70 acres site with a built up area of around 97000 sq metres. Phase I will have installed capacity of about 7,500 million tablets / capsules and 25 MT API per annum. The plant will cater mainly to the more regulated international markets such as the US, Brazil and Germany.
Construction of phase II will commence soon and once commissioned the total capacity will increase to about 14,000 million tablets / capsules and 80 MT API per year.